Presentation Information

[D1-A3-05]Challenges in Flow Cytometry Biomarker Assessment from Non-Clinical to Clinical

*Satomi Sugiyama1 (1. Astellas Pharma Inc.)

Password required to view


Comment

To browse or post comments, you must log in.Log in